Wei Li
5PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 15, 2023
Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.Jessica Limberg, Caitlin E Egan, Katherine D Gray
|Nov 20, 2020
Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma.Fuxin Li, Wei Li, Katherine D Gray
|Oct 13, 2018
CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.Wei Li, Shujun Xia, Anna Aronova
|Apr 17, 2018
Therapy of cervical cancer using 131I-labeled nanoparticles.Wei Li, Danyang Sun, Ning Li
|Nov 18, 2015
Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.Wei Li, Zhongyun Liu, Chengxia Li
Pageof 1
Frequent Collaborators
1 joint publications
Jessica Limberg
1 joint publications
Caitlin E Egan
1 joint publications
Katherine D Gray
1 joint publications
Mandeep Singh
1 joint publications
Zachary Loewenstein
1 joint publications
Yanping Yang
1 joint publications
Maria Cristina Riascos
1 joint publications
Hala Al Asadi
1 joint publications
Parima Safe
1 joint publications
Steve El Eshaky
